FASTinov Celebrates Success: Completes 6 Customer Evaluations with Outstanding Feedback
June 3rd 2023
(Porto, Portugal) – FASTinov, the global leader in rapid antimicrobial susceptibility testing (AST), is thrilled to announce another significant milestone in its journey towards transforming sepsis management. On June 3, 2023, FASTinov successfully completed evaluations at six esteemed hospitals, receiving overwhelmingly positive feedback from customers.
Throughout these evaluations, customers lauded FASTinov’s innovative technology for its ability to consistently deliver timely and accurate antibiograms to clinicians. With results available by lunchtime, healthcare professionals can now make informed treatment decisions swiftly, revolutionizing the management of sepsis.
The exceptional feedback from customers underscores the transformative impact of FASTinov’s AST solution on patient care. By providing actionable insights in a fraction of the time previously possible, FASTinov is empowering healthcare providers to deliver targeted and effective treatment strategies, ultimately saving lives.
“We are immensely proud of the success of these evaluations and the positive feedback we have received. This achievement is a testament to the dedication of our team and the transformative potential of our technology in sepsis management.”
With each successful evaluation, FASTinov reaffirms its commitment to delivering innovative solutions that address the urgent needs of healthcare providers worldwide. By leveraging cutting-edge technology, FASTinov continues to lead the charge in the fight against sepsis, offering hope and improved outcomes for patients everywhere.
About FASTinov
FASTinov is a leading innovator in rapid antimicrobial susceptibility testing, dedicated to revolutionizing patient care in sepsis contexts. With a mission to provide actionable same-shift results, FASTinov’s cutting-edge technology offers healthcare professionals unprecedented insights for targeted treatment decisions.
- For media inquiries, please contact: info@fastinov.com
Share with friends
© 2022